Form 8-K - Current report:
SEC Accession No. 0000950170-25-065613
Filing Date
2025-05-07
Accepted
2025-05-07 16:04:40
Documents
13
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dsgn-20250507.htm   iXBRL 8-K 50226
2 EX-99.1 dsgn-ex99_1.htm EX-99.1 138721
3 GRAPHIC img267412975_0.jpg GRAPHIC 107166
  Complete submission text file 0000950170-25-065613.txt   466094

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dsgn-20250507.xsd EX-101.SCH 26968
15 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20250507_htm.xml XML 5111
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 25921190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)